LYMErix* Becomes First Lyme Disease Vaccine on the Market New Haven, CT – LYMErix*, pioneered by Yale University researchers and manufactured by SmithKline Beecham Biologicals, has received approval from the U.S. Food and Drug Administration (FDA) for...
A simple test of the ability to tell time and count change may provide a new approach to screening for Alzheimer’s disease and other forms of dementia in older adults, according to a study in this week’s Journal of the American Geriatrics Society and an...
Dr. Thomas Zeltner, director general of the Swiss Federal Office of Public Health, will explain his country’s fourfold approach to reducing the problems associated with drug addiction on Tuesday, Dec. 15, at Public Health Grand Rounds. The talk is free...